Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Pharmacology, Biochemistry, and Behavior
|
October 7, 2022
Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability
Hayley N Manke, Katharine H Nelson, Shihui Huang, et al.
Molecular Pain
|
November 28, 2025
Single cell transcriptomic analysis reveals dynamic cellular composition changes at acupuncture point BL23 (Shenshu) in low back pain
Gexin Zhao, Xiuju Wu, Shunfa Huang, et al.
Journal of Medicinal Chemistry
|
March 13, 2024
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry
|
January 13, 2026
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
Xingxing Cheng, Zheqi Hu, Huihuan Mao, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Pharmacology, Biochemistry, and Behavior
|
October 7, 2022
Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability
Hayley N Manke, Katharine H Nelson, Shihui Huang, et al.
Molecular Pain
|
November 28, 2025
Single cell transcriptomic analysis reveals dynamic cellular composition changes at acupuncture point BL23 (Shenshu) in low back pain
Gexin Zhao, Xiuju Wu, Shunfa Huang, et al.
Journal of Medicinal Chemistry
|
March 13, 2024
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry
|
January 13, 2026
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
Xingxing Cheng, Zheqi Hu, Huihuan Mao, et al.
Page
of 7